INCA 0186

· Incyte Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INCA 0186, covering 2025-09-02 to 2025-09-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of INCA 0186 in Subjects With Advanced Solid Tumors [Phase 1]